EichorEICHORAboutSolutions
Condition: Cpvt1 Synced from ClinicalTrials.gov · August 06, 2026

Recruiting studies: Cpvt1

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Safety, Tolerability, and Exploratory Efficacy of AGP100 in Patients With Catecholaminergic Polymorphic Ventricular Tach
Phase 2 · 1 location(s) · Agiana Pharmaceuticals · NCT07263139Evaluation of Exercise Testing and Physical Activity in Children and Adolescents Living With Inherited Arrhythmias
Phase N/A · 2 location(s) · Royal Brompton & Harefield NHS Foundation Trust · NCT06661278National Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in Brazil's Un
Phase N/A · 27 location(s) · Hospital do Coracao · NCT06546137A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
Phase 1 · 5 location(s) · Solid Biosciences Inc. · NCT07148089China Inherited Ventricular Arrhythmias Registry
Phase N/A · 1 location(s) · China National Center for Cardiovascular Diseases · NCT03880708Genetic Markers of Cardiovascular Disease in Epilepsy
Phase N/A · 1 location(s) · Mayo Clinic · NCT02824822Clinical Cohort Study - TRUST
Phase N/A · 1 location(s) · Universitätsklinikum Hamburg-Eppendorf · NCT05521451A Phase 2 Study of CRD-4730 in CPVT
Phase 2 · 12 location(s) · Cardurion Pharmaceuticals, Inc. · NCT06658899
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.